Literature DB >> 34908752

Risk factors associated with human immunodeficiency virus infection in blood donors in Iran: A case-control study.

Fariba Seighali1,2, Nasim Sadat Hosseini Divkolaye2,3, Negar Rezaei4,5, Masumeh Kangarloo6.   

Abstract

BACKGROUND: Despite setting the stringent criteria for the selection of safe donors, some human immunodeficiency virus (HIV)-positive volunteers manage to give blood. Considering the window period of screening tests, this could endanger the safety of blood supply.
MATERIALS AND METHODS: A frequency match case-control study was conducted on HIV-positive and negative blood donors in Iran from 2007 to 2008. Overall, 61 HIV-positive and 224 HIV-negative blood donors were selected as cases and controls, respectively. Two groups were matched for confounding factors. An identical questionnaire was used to assess risk factors. Univariate regression analysis for calculating crude odds ratio (OR) and 95% confidence interval (CI) was used for detecting eligibility of risk factors to enter the final model. The exposures with P < 0.1 were entered in the logistic regression model. Adjusted ORs with P < 0.05 and 95% CIs were reported for statistically significant variables.
RESULTS: Significant effects were detected for the following variables: education, job, tattoo, intravenous (IV) drug abuse, imprisonment, and risky sexual behavior. However, based on multiple analyses, education, IV drug abuse, imprisonment, and risky sexual behavior remain significant.
CONCLUSION: The majority of our findings are in parallel with the other studies performed in other countries. To increase blood safety, special attention should be paid to illiterate, first-time blood donors who are in the 25-40 age range. In addition, having the history of IV drug abuse, imprisonment and risky sexual behaviors put the blood donors more at risk of infecting HIV. Copyright:
© 2021 Asian Journal of Transfusion Science.

Entities:  

Keywords:  Blood donors; Iran; human immunodeficiency virus; risk factor

Year:  2021        PMID: 34908752      PMCID: PMC8628243          DOI: 10.4103/ajts.AJTS_47_18

Source DB:  PubMed          Journal:  Asian J Transfus Sci        ISSN: 0973-6247


Introduction

Providing safe and sufficient blood is the most important mission of all blood transfusion services. To this end, Iranian blood transfusion organization (IBTO) developed stringent criteria for selection of safe donors such as encouraging regular blood donation and retaining safe blood donors; providing informative and educational materials about the main risk factors; improving public health programs with a focus on counseling and screening of those engaged in high-risk activities; predonation screening through interviews, filling precise questionnaire, and brief physical examinations; and implementing a uniform self-deferral procedure and confidential unit exclusion.[1] Physicians in donor selection department are trained before starting their work and continuously in related courses. IBTO screens 100% of donated blood for transfusion-transmitted infections (TTI). Screening of donated blood for hepatitis B surface antigen (HBsAg) became mandatory since the establishment of IBTO in 1974. However, screening of blood units for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) started from 1989 to 1996, respectively.[2] In Iran, the overall prevalence rate of HIV infection among blood donors, during the last 5 years, was 0.003%.[3] However, according to the UNAIDS, the number of people living with HIV in Iran is estimated to be 66000 (37,000–120,000) in 2016; in another word, the prevalence of HIV is about 0.1% among Iranian adult population (15–49 years old).[4] As expected, the prevalence of HIV is considerably lower among blood donors comparing to general population. However, despite the policies set to exclude people with high-risk behaviors, some few HIV-infected volunteers manage to donate. Considering the window period of screening tests, this could endanger the safety of blood supply. Several studies carried out to identify the most important risk factors among HBsAg and HCV-positive blood donors in Iran.[56] However, there has not been any comprehensive data about the risk factors of HIV-positive blood donors. This study aims to address this lack of information and evaluates the main risk factors of Iranian HIV seropositive blood donors.

Materials and Methods

A frequency match case–control study was conducted on HIV-positive and negative blood donors in Iran from 2007 to 2008. The delay in reporting the data was mainly attributed to the problems that were faced in collecting the data of control group in terms of their consistency and confounding factors. Overall, 61 HIV-positive and 224 HIV-negative blood donors were selected as cases and controls, respectively. To reduce selection bias and confounding, 1:4 cases and control frequency matching by age, gender, and times of donation (first time, regular or repeat donor) was performed. Their ages were matched based on 10-year period categories, and the controls were selected and recalled according to their inclusion in each category. The same method was used for the matching their sex. An identical questionnaire was used for both the cases and controls to assess risk factors for HIV. All participants agreed to complete the questionnaire and signed an informed consent. The questionnaire was developed (to assess HIV risk factors among blood donors) by consulting experts, based on the national standards of procedures in IBTO. To exclude the errors and defects, the questionnaire was firstly filled by 35 HIV-positive blood donors and 100 HIV-negative blood donors in a pilot. The questionnaire contained items on sociodemographic characteristics and risk factors. Sociodemographic characteristics included gender, age, marital status, level of education, and occupation. Risk factors included phlebotomy (Hijamat), tattoo, blood transfusion, intravenous (IV) drug abuse, imprisonment, risky sexual behavior (sex with HIV-positive person, sex with more than one partner, extramarital sex, male–male sex, and history of sexually transmitted disease). The questionnaires were completed by the medical doctors at blood centers in predonation interview at a private room, through a face-to-face process, and were collected in special boxes. To observe confidentiality, the name and donation number was deleted from the questionnaire.

Case and control definitions

Based on the policy of IBTO, volunteers who have positive ELISA test are permanently deferred to donate blood. Then, confirmatory test must be done, and the positive cases are recalled and requested to turn back to repeat the confirmatory test with different kits. These donors after positive repeated tests have been requested to fill in the questionnaire as cases. Control group was selected four times more than cases among blood donors who had negative HIV serologic tests from the same database of cases who had accepted our invitation to participate in the study. Control group were frequently matched with cases in terms of age, gender, and times of donation. Phone recalls were made based on the results of HIV + confirmatory tests to the donors. Accordingly for each HIV-positive case, a person from control group was recalled to fill the questionnaire.

Laboratory methods

The donations were all screened for HIV antigen/antibody by Vironostika HIV antigen/antibody (Bio Merieux)-Fourth generation or HIV antigen/antibody (Bio-Rad)-Fourth generation kits. Every sample that was found to be positive in the screening test was retested; and if it was constantly positive, retesting was performed by HIV BLOT 2.2 (MP Diagnostic) and INNO-LIA, HIV 1/2 score (Innogenetics) as a confirmatory test.

Statistical analysis

First, to evaluate univariate analysis between HIV-positive blood donors and the expected exposures, the models were run separately. The models included the risk factors of the questionnaire as independent variables and HIV as the dependent variable. The sociodemographic characteristics of the cases and controls were assessed, and the risk factors were compared with univariate analysis for calculating crude odds ratio (OR) and 95% confidence interval (CI) and eligibility to enter the final model. The exposures with P < 0.1 were entered in the multiple logistic regression model. Consequently, a backward stepwise selection method was used to build multiple models that restricted to all the risk factors that were independently associated with HIV. Adjusted ORs with P < 0.05 and 95% CIs were reported for significant variables. Confounding bias was identified as a consequence of the change in OR before and after adjustment for the confounding variable. All the analyses were performed with computer software (SPSS 22, SPSS, IBM Inc.). The study was ethically approved by the Ethics Committee of Iranian High Institute for Research and Education. The confidentiality of data was preserved during the study.

Results

Of all 89 confirmative positive HIV blood donors in 2007–2008 who were called, 61 cases filled in the questionnaire. Of 28 excluded cases, 13 were given wrong telephone number and address (47%), 8 did not return despite former willingness during the first recall (29%), and 7 did not have phone number or had remote home address (24%). Compared to 61 cases, 244 controls were selected from blood donors who had negative HIV serologic tests. Of 61 cases, 5 were female (8.2%) and 56 (91.8%) were male. Cases were more likely between 30 and 40 years old (39.3%). Sixty-seven point two percent of cases were first-time blood donors and 32.8% were lapsed donors. Successful frequency matching enrolment approach leads to enhanced age group, sex, and blood donation type distribution in the final sample. The participants' donation status and sociodemographic and relevant characteristics are presented in Table 1.
Table 1

Sociodemographic characteristics and donation status of participants

HIV positiveHIV negative P
Gender
 Female5 (8.2)8 (3.3)0.14
 Male56 (91.8)236 (96.7)
Age (year)
 <3016 (26.2)81 (33.3)0.54
 30-3924 (39.3)85 (35)
 40-4917 (27.9)54 (22.2)
 ≥504 (6.6)23 (9.5)
Occupation
 Unemployed10 (16.4)15 (6.2)0.01
 Employed50 (82)210 (86.4)
 Student1 (1.6)18 (7.4)
Education
 Illiterate8 (13.1)6 (2.5)<0.001
 High school48 (78.7)155 (64)
 Academic5 (8.2)81 (33.5)
Marital status
 Single20 (32.8)66 (27)0.26
 Married38 (62.3)173 (70.9)
 Divorced3 (4.9)5 (2)
Type of donation
 First-time donors41 (67.2)162 (66.4)0.9
 Lapsed donors20 (32.8)82 (33.6)

HIV=Human immunodeficiency virus

Sociodemographic characteristics and donation status of participants HIV=Human immunodeficiency virus Table 2 displays a comparison of potential crude and adjusted OR of significant exposures and 95% CI.
Table 2

Comparison of potential crude and adjusted odds ratio of significant exposures and 95% confidence interval

OR crude (CI 95%) P OR adjusted (CI 95%) P
Exposure
 Education
  IlliterateReferenceReference
  High school0.23 (0.07-0.7)0.010.11 (0.03-0.42)0.001
  Academic0.04 (0.01-0.1)<0.0010.04 (0.008-0.2)<0.001
 IVDU91.42 (26.28-317.99)<0.00118.24 (4.27-77.76)<0.001
 History of imprisonment159.33 (20.9-1214.19)<0.00115.63 (1.54-158.12)0.02
 Unsafe sex10.55 (5.52-20.19)<0.0013.18 (1.18-8.51)0.02
 Gender0.38 (0.12-1.25)0.14
 Phlebotomy0.85 (0.43-1.67)0.63
 Tattoo4.87 (2.17-10.89)<0.001
 Blood transfusion2.65 (0.83-8.44)0.14
 Job
  No jobReference
  Occupied0.35 (0.15-0.84)0.01
  Student0.08 (0.01-0.72)0.02
 Age
  <30Reference
  30-401.42 (0.7-2.88)0.31
  40-501.59 (0.74-3.42)0.23
  50<0.88 (0.26-2.89)0.83
 Marital status
  Divorce/widowReference
  Married0.36 (0.08-1.59)0.2
  Single0.5 (0.11-2.30)0.37
Covariate
 Education
  LowReferenceReference
  Medium0.23 (0.07-0.7)0.010.11 (0.03-0.42)0.001
  High0.04 (0.01-0.1)<0.0010.04 (0.008-0.2)<0.001

IVDUs=Intravenous drug users, OR=Odds ratio, CI=Confidence interval

Comparison of potential crude and adjusted odds ratio of significant exposures and 95% confidence interval IVDUs=Intravenous drug users, OR=Odds ratio, CI=Confidence interval Based on univariate analysis, significant association was detected for the following variables: education, job, tattoo, IV drug abuse, imprisonment, and risky sexual behavior. However, based on multiple analyses, education, IV drug abuse, imprisonment, and risky sexual behavior remain significant. It seems that job and tattoo were confounded by other exposures. In univariate model HIV positivity in occupied and students were less than jobless patients, tattoo increased the risk of HIV four times compared to control but neither was significant in multiple models. Phlebotomy (Hijamat) (the Hijamat is the name of the traditional Islamic healing technique and the method includes removing blood from the body to attain remedy and consists of cupping and scarification of the specific skin area of the body) and history of blood transfusion based on univariate analysis were not significantly different between two groups. In terms of educational levels, illiteracy was more frequent among cases (13.1%) comparing to 2.5% among controls. Higher education has a protective role against HIV positivity. The protective roll became robust by increasing the educational level comparing to illiterate participants (academic level OR adj: 0.04, CI 95%: 0.008–0.2 and high school level OR adj: 0.11, CI 95%: 0.03–0.42. In the absence of confounding effect of other exposures, Intravenous Drug Users (IVDUs), prisoners, and persons with high-risk sex behaviors had HIV infection more than controls, about 18, 15, and 3 times, respectively (IVDU OR adj: 18.24, CI 95%: 4.27–77.76; imprison OR adj: 15.63, CI 95%: 1.54–158.12; and unsafe sex OR adj: 3.18, CI 95%: 1.18–8.51). In HIV-positive cases, having multiple risk factors at the same time were frequent. About 29% (18 blood donors) of HIV-positive cases had all significant risk factors, but in HIV-negative group, there was no participant with multiple risk factors. In 7.3% (17 blood donors) of HIV-positive cases and 96.4% (216 blood donors) of controls, no risk factor was reported.

Discussion

The study found the main HIV risk factors among Iranian blood donors who donated blood during 2007–2008. Results indicate that, illiteracy, and having the history of IV drug abuse, imprisonment and risky sexual behaviors are associated with the risk of HIV positivity among blood donors. In addition, being in the 30–40 age range and first-time donor were significantly prevalent among cases comparing to general population. The rate of male/female ratio of HIV seropositive blood donors (91.8/8.2%) did not have any significant difference comparing to general population of blood donors (92/8%) and general population of HIV positives in 2007 in Iran (93/7%).[7] In our study, we found some demographic characteristics make volunteer to be at more risk. Middle-aged and first-time blood donors are more likely to be at risk of infecting HIV. However, the population of Iranian blood donors was mostly between 20 and 30 years old (36.7%) in 2007.[7] Furthermore, in general population of HIV infected, cases were mostly (46.4%) in the 25–34 age range.[8] In 2012, Mariston et al. found that being at the 29–39 age range is most prevalent among HIV-positive blood donors.[9] In another study carried out in Malawi, there was a highly significant positive association of HIV prevalence with being in the age group of 25–29 years for females and 30–34 years for males. The minor discrepancy that exists in the age group of our study comparing to general population of HIV infected cases may be related to the higher level of knowledge among young blood donors about the negative effects of HIV test-seeking behavior which is the result of growing IBTO awareness-raising campaigns among university students and young people. Furthermore, the majority of our cases were male, and as it was found in the study of Malawi, men tend to be older than women among cases. Our results indicate that cases are mostly first-time blood donors (67%). This confirms the findings of another study in which Amini et al. found that the frequency of HIV in repeat blood donors is significantly less than first-time blood donors between 2006 and 2007.[10] In another study that analyzed the prevalence of HIV among Brazilian blood donors, it was shown that HIV prevalence was 22% higher among the first-time donors than replacement donors.[9] Illiteracy was more frequent among cases than controls (13.1% vs. 2.5%). Illiterate individuals were found to present the highest risk of being HIV-positive donor candidates in Brazil.[10] It may be because of lower rate of risky behavior among educated people or higher educated HIV positives may not tend to donate because of their knowledge. Among known HIV risk factors, we did not recognize any significant association between HIV positivity, doing phlebotomy (Hijamat), and history of blood transfusion. Based on the National Blood Policy in Iran, doing Hijamat defers volunteer from blood donation for 6 months. These results confirm the finding of the report of the Ministry of Health which indicates that since 2007, there has not been any reported case of HIV positive through blood transfusion.[11] However, being IV drug abuser, having a history of imprisonment and risky sexual behaviors are found to have significant effects on HIV positivity. Given a large proportion of prisoners is drug addicts, these findings were compatible with other studies conducted in Iran and some countries which suggest that drug injection inside prison carries more risk for HIV infection.[1213] The prevalence of HIV is 13.4% among injecting drug users which is dramatically high comparing to general population.[14] In a study among community-based drug users in Tehran, the prevalence of HIV infection was reported 23.2% among male IVDUs. In a multiple analysis, a history of shared drug injection inside prison (OR: 2.5) and multiple incarcerations (OR: 3.13) were associated with a significantly higher prevalence of HIV infection.[15] Other studies conducted among IV drug users in Tehran support our results, in which a history of shared injection inside prison found to be the most important risk factor associated with HIV infection.[1617] After injecting drugs, a significant proportion (17.1%) of registered cases of HIV transmission in Iran is attributed to unsafe sexual contact.[18] Although having male–male sex identified as the most significant risk factor in other countries, (in Brazil[19] and United States[20]) in Iran, having risky sexual behaviors came third of importance. This may due to religious beliefs and criminal laws which bans Iranians from this kind of relation. Nevertheless, in the biobehavioral survey of inmates in 2009, 15.6% of men reported sexual contact with other men. The prevalence of HIV among this subset of MSM was found to be 3.7%. 1.[5] We believe that most of our excluded cases may have some risk factors. These donors gave wrong address or phone number and some did not return despite former willingness during the first recall. They may mostly be test seekers who did not give right personal details to escape from aftermath consequences. In a study conducted in Brazil in 2010, it was reported that test seeker HIV-positive blood donors believe that it is ok not to answer questions truthfully to donate blood and get tested for HIV through donation.[21] Due to few numbers of cases, we were unable to identify prevalent risk factors in each province. In provinces with more HIV positives such as Kermanshah and Golestan,[22] the rate of deferral from blood donation was lower than average rate of deferral in the whole country which was 25.6% in the same year;[23] and in other HIV prevalent provinces such as Tehran,[24] Fars, and Hormozgan,[22] it was equal to that rate. Considering the high prevalence of HIV in those provinces, it is necessary to apply more stringent criteria for the selection of blood donors.

Conclusion

In donor selection step, attention should be paid to the vulnerable population, especially first time who are in the age range of 25–40. The staff of donation department staff should be trained regularly and receive feedback about donors who will be positive for TTI.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  15 in total

1.  Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand.

Authors:  S Vanichseni; D Kitayaporn; T D Mastro; P A Mock; S Raktham; D C Des Jarlais; S Sujarita; L O Srisuwanvilai; N L Young; C Wasi; S Subbarao; W L Heyward; L Esparza; K Choopanya
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran.

Authors:  Saman Zamani; Masahiro Kihara; Mohammad M Gouya; Mohsen Vazirian; Bijan Nassirimanesh; Masako Ono-Kihara; Shahrzad Mortazavi Ravari; Afshin Safaie; Seiichi Ichikawa
Journal:  J Acquir Immune Defic Syndr       Date:  2006-07       Impact factor: 3.731

Review 3.  HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007.

Authors:  Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Ali-Akbar Haghdoost; Behnam Sadeghirad; Minoo Mohraz
Journal:  Int J Drug Policy       Date:  2011-10-14

4.  Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran.

Authors:  Saman Zamani; Masahiro Kihara; Mohammad Mehdi Gouya; Mohsen Vazirian; Masako Ono-Kihara; Emran Mohammad Razzaghi; Seiichi Ichikawa
Journal:  AIDS       Date:  2005-04-29       Impact factor: 4.177

5.  Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: a case-control study.

Authors:  Negar Rezaei; Sedigheh Amini-Kafiabad; Mahtab Maghsudlu; Hasan Abolghasemi
Journal:  Transfusion       Date:  2016-06-06       Impact factor: 3.157

6.  Four decades of National Blood Service in Iran: outreach, prospect and challenges.

Authors:  A A Pourfathollah; N S Hosseini Divkolaye; F Seighali
Journal:  Transfus Med       Date:  2015-06-04       Impact factor: 2.019

7.  Prevalence of Human Immunodeficiency Virus in Iranian Blood Donors: A Systematic Review and Meta-Analysis.

Authors:  Hadis Musavi; Hamideh Rahimi; Wesam Kooti; Ruhollah Dorostkar; Milad Azami; Maedeh Sharghi; Hadis Ashrafi-Zadeh; Mohammad Firoozbakht; Ramezan Ali Taheri
Journal:  Arch Iran Med       Date:  2018-06-01       Impact factor: 1.354

8.  Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case-control study using audio computer-assisted structured interviews.

Authors:  C de Almeida-Neto; T T Goncalez; R J Birch; S M F de Carvalho; L Capuani; S C Leão; C Miranda; P C Rocha; A B Carneiro-Proietti; B R Johnson; D J Wright; E L Murphy; B Custer
Journal:  Vox Sang       Date:  2013-03-20       Impact factor: 2.144

9.  Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.

Authors:  Sedigheh Amini Kafi-abad; Houri Rezvan; Hassan Abolghasemi; Ali Talebian
Journal:  Transfusion       Date:  2009-06-10       Impact factor: 3.157

10.  Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.

Authors:  Mohammad Mehdi Mir-Nasseri; Ashraf Mohammadkhani; Hamid Tavakkoli; Esmaeil Ansari; Hossein Poustchi
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.